| 01 Sept, 01:50 am | other | 0 | Sun Pharma participated in a White House signing ceremony highlighting U.S. medicines pricing and access commitments, a non-commercial event with no financial or operational impact. | nse |
| 17 Aug, 08:40 am | — | … | Update on Lipitor Antitrust Litigation | nse |
| 06 Aug, 08:34 pm | — | … | Receipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group | nse |
| 06 Aug, 05:04 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 06 Aug, 04:58 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript | nse |
| 05 Aug, 09:18 am | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 05 Aug, 09:17 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Credit Rating | nse |
| 31 Jul, 10:22 pm | — | … | Voting Results and Scrutinizer Report of 34th AGM held on 31 July 2026 | nse |
| 31 Jul, 08:11 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Q1FY27-Investor Call Audio Recording | bse |
| 31 Jul, 08:05 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Link of Recording | nse |
| 31 Jul, 06:18 pm | — | … | Conclusion of the Board Meeting held today, i.e., 31 July 2026 | nse |
| 31 Jul, 02:30 pm | — | … | Unaudited Standalone and Consolidated Financial Results for Q1 of FY 2026-27 | nse |
| 31 Jul, 02:28 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Unaudited Standalone And Consolidated Financial Results For Q1 Of FY 2026-27 | bse |
| 29 Jul, 10:00 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Jul, 09:59 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Sun Pharma receives approval to manufacture and market semaglutide in Brazil". | nse |
| 27 Jul, 04:00 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Update on Nidlegy | nse |
| 24 Jul, 08:50 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 24, 2026, titled "Sun Pharma Notes Organon Shareholder Approval for Proposed Acquisition". | nse |
| 24 Jul, 08:50 am | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 15 Jul, 08:40 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 15, 2026, titled "Sun Pharma receives approval to manufacture and market generic semaglutide in South Africa". | nse |
| 15 Jul, 08:40 am | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Jul, 03:47 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026 | bse |
| 07 Jul, 04:24 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 07 Jul, 04:20 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation | nse |
| 06 Jul, 06:57 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Reg. 34 (1) Annual Report. | bse |
| 20 Jun, 05:23 pm | — | … | Acquisition of Innovcare Lifesciences Private Limited | nse |
| 20 Jun, 05:23 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 16 Jun, 07:21 pm | — | … | Newspaper Publication containing information about transfer of equity shares and unclaimed dividends to the Investor Education and Protection Fund (IEPF) Account | nse |
| 14 Jun, 11:44 am | other | 1 | Sun Pharmaceutical Industries informed that Independent Director Mr. Gautam Doshi has been arrested, stated the matter is not connected with the company, and said no impact is envisaged on the company or its Board processes. | nse |
| 11 Jun, 10:56 pm | dividend_buyback | 1 | Sun Pharma has announced the record date for the final dividend per its corporate action schedule. | bse |
| 11 Jun, 10:55 pm | dividend_buyback | 1 | Sun Pharma has set 07-Jul-2026 as the record date for its final dividend. | nse |
| 11 Jun, 02:32 pm | procedural | 0 | Company intimates 34th AGM and record date for final dividend and related matters; no financial impact disclosed beyond the dividend record date. | nse |
| 29 May, 08:08 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 29 May, 07:59 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript | nse |
| 26 May, 09:16 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Filing of Application for reclassification with stock exchanges | nse |
| 26 May, 06:24 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated May 26, 2026, titled "At the ASCO® 2026 Annual Meeting, Sun Pharma to Present Pivotal Long-Term Follow-up Data on UNLOXCYT (cosibelimab-ipdl)". | nse |
| 26 May, 06:23 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 May, 01:45 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Newspaper Publication of Financial Results for year ended 31 March 2026 | nse |
| 22 May, 08:58 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Investor Call Audio Recording | bse |
| 22 May, 08:53 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Link of Recording | nse |
| 22 May, 06:17 pm | — | … | Additional Outcome of the Board Meeting | nse |
| 22 May, 03:05 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2026, recommended Final Dividend of Rs. 5 per equity share. | nse |
| 22 May, 03:02 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Board Meeting Outcome for Recommendation Of Final Dividend | bse |
| 22 May, 02:59 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Financial Results and Recommendation of Dividend for FY 2025-26 | nse |
| 22 May, 02:54 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Financial Results For The Quarter And Year Ended 31 March 2026 | bse |
| 22 May, 02:43 pm | — | … | Sun Pharmaceutical Industries Limited has submitted to the Exchange, the Audited Financial Results for the quarter and year ended 31 March 2026. | nse |
| 18 May, 05:32 pm | — | … | Dilip S. Shanghvi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 14 May, 12:25 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Receipt of requests for reclassification of shareholder category | nse |
| 12 May, 05:20 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 12 May, 05:20 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 11 May, 07:13 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Board Meeting Intimation for Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended 31 March 2026 And Recommendation Of Final Dividend For FY 2025-26 | bse |